KWF

INTER-LOCAL: International Funding Call for Clinical Research on Local Treatment Strategies

Up to €3M| Deadline: 18 June 2026 (3 days)|Up to 6 years

Full proposal closure: 18 June 2026, 12:00 noon CEST. Pre-proposal phase already closed (22 Jan 2026). Only invited applicants may submit full proposals.

Last verified: 14 June 2026

Details

Funder	KWF
Budget	Up to €3M
Deadline	18 June 2026
Duration	Up to 6 years
Consortium	Required — partners from at least 3 of 5 funding countries (Belgium, Netherlands, Spain, Norway, Sweden)
Application	2-stage: pre-proposal (closed 22 Jan 2026) → full proposal (open 27 Apr 2026, closes 18 Jun 2026); rebuttal week 7 Sep 2026; funding decision 27 Oct 2026
Frequency	One-off
Eligible countries	BENLESNOSE

Eligibility & scope

Late-phase (phase 2/3) international clinical trials on radiotherapy or surgery for rare cancers (incidence <6/100,000/yr) and/or hard-to-treat cancers (5-yr survival <25%). Consortium must include partners from ≥3 of 5 funding countries (BE, NL, ES, NO, SE). Five projects invited to full proposal phase; submission via Swedish Cancer Society's Grant Application System.